The federal government isn’t considering putting up money to help buy shares in the only domestic manufacturer of COVID-19 vaccines, but it is “working on a solution” with Medicago’s parent company.
While meeting with the presidents of Mitsubishi Tanabe Pharma and Mitsubishi Chemical, which owns a 79 per cent stake in Medicago, Champagne says there were discussions about the company’s future as a global vaccine manufacturer.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Profitable companies don’t deserve my taxes. Stop it.